August 21, 2023

ACT For Health welcomes C3 Medtech to its portfolio

India faces a daunting healthcare challenge with an estimated 270 million people experiencing vision loss. Among them, 9.2 million individuals are burdened with irreversible blindness and shockingly, 90% of these cases are preventable. The lack of access to quality eye care, especially in rural areas, has exacerbated this crisis, leaving millions without the opportunity to see the world around them. This has huge implications on quality of life and the overall economy of the country.

We strongly believe that there is a pressing need for Point-of-Care (PoC) devices in peripheral settings that can be easily operated by any frontline health worker with minimal training. That’s why we have decided to support C3 Medtech’s eye screening solutions to help bridge the gap on quality ophthalmology care for underserved communities and facilitate wider adoption of the solution in primary care settings. C3 Medtech’s solution plays a crucial role in the early screening of conditions such as cataract, corneal opacity, glaucoma, and diabetic retinopathy, which are the major causes of blindness in India. By doing so, it significantly contributes to the fight against preventable blindness.

Traditionally, both slit lamps (used for anterior eye inspection) and fundus devices (used for retinal examination) have been bulky and expensive, requiring trained ophthalmologists to operate. However, C3 Medtech has developed a portable slit lamp and a fundus imaging device, which are powerful eye screening solutions that empower primary care settings to conduct efficient screenings, facilitating early detection and timely treatment for various eye conditions. The best part is that these innovative devices can be easily attached to smartphones, allowing healthcare providers to capture high-quality eye images and receive remote consultations from qualified ophthalmologists.

They are simple to operate with minimal training, making them ideal for use in primary care settings in remote regions. They effectively address the challenges faced in reaching underserved communities and offer a cost-effective solution for resource-constrained environments, where access to advanced eye care technology has historically been limited.

ACT For Health will support the deployment of 30 sets of C3 Medtech eye screening devices within our implementation partner network and charitable institutes operating in low resource settings. Our support will help them in getting real life market feedback and pathways to scale in peripheral settings and we’re excited to collaborate with them on enabling better access to quality yet affordable ophthalmology care!

Related Posts

ACT Capital Foundation For Social Impact is a not-for-profit company incorporated and registered under Section 8 of the Companies Act, 2013. All donations made to ACT Capital Foundation are eligible for income tax deduction under Section 80G of the Income Tax Act.

ACT Capital Foundation For Social Impact © 2021 | All Rights Reserved

Site handcrafted by:  TWN